207 related articles for article (PubMed ID: 27221238)
41. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
[TBL] [Abstract][Full Text] [Related]
43. Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynaecol Obstet; 2017 Oct; 139(1):90-94. PubMed ID: 28632949
[TBL] [Abstract][Full Text] [Related]
44. High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.
Bhatta MP; Johnson DC; Lama M; Aryal S; Lhaki P; Shrestha S
BMC Infect Dis; 2017 Jan; 17(1):73. PubMed ID: 28088173
[TBL] [Abstract][Full Text] [Related]
45. High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.
Tanton C; Soldan K; Beddows S; Mercer CH; Waller J; Field N; Clifton S; Copas AJ; Panwar K; Manyenga P; da Silva F; Wellings K; Ison CA; Johnson AM; Sonnenberg P
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):842-53. PubMed ID: 25737331
[TBL] [Abstract][Full Text] [Related]
46. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China.
Wang J; Tang D; Wang J; Zhang Z; Chen Y; Wang K; Zhang X; Ma C
Hum Vaccin Immunother; 2019; 15(7-8):1889-1896. PubMed ID: 30735478
[No Abstract] [Full Text] [Related]
47. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
49. Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies.
Wei F; Xia N; Ocampo R; Goodman MT; Hessol NA; Grinsztejn B; Ortiz AP; Zhao F; Kojic EM; Kaul R; Heard I; Morhason-Bello IO; Moscicki AB; de Pokomandy A; Palefsky JM; Rodrigues LLS; Dube Mandishora RS; Ramautarsing RA; Franceschi S; Godbole SV; Tso FK; Menezes LJ; Lin C; Clifford GM
J Infect Dis; 2023 Feb; 227(4):488-497. PubMed ID: 35325151
[TBL] [Abstract][Full Text] [Related]
50. Cervical Human Papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study.
Orlando G; Bianchi S; Fasolo MM; Mazza F; Frati ER; Rizzardini G; Matteelli A; Zanchetta N; Amendola A; Tanzi E
J Prev Med Hyg; 2017 Dec; 58(4):E259-E265. PubMed ID: 29707656
[TBL] [Abstract][Full Text] [Related]
51. Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
Inturrisi F; Lissenberg-Witte BI; Veldhuijzen NJ; Bogaards JA; Ronco G; Meijer CJLM; Berkhof J
Int J Cancer; 2021 Jan; 148(2):320-328. PubMed ID: 32663316
[TBL] [Abstract][Full Text] [Related]
52. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
53. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.
Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Pearse A; Montoya GD; Robertson M; Shearman CA; Castle PE;
Int J Cancer; 2013 Jan; 132(1):198-207. PubMed ID: 22532127
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
55. Cervical cytology and HPV distribution in Cape Verde: A snapshot of a country taken during its first HPV nation-wide vaccination campaign.
Vieira R; Montezuma D; Barbosa C; Macedo Pinto I
Tumour Virus Res; 2024 Jun; 17():200280. PubMed ID: 38621479
[TBL] [Abstract][Full Text] [Related]
56. Pre-vaccination prevalence of high-risk human papillomaviruses (HPV) in women from Kosovo and their related sociodemographic characteristics.
Zejnullahu Raçi P; Hošnjak L; Poljak M; Lepej SŽ; Vince A
Ginekol Pol; 2018; 89(9):485-494. PubMed ID: 30318575
[TBL] [Abstract][Full Text] [Related]
57. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
[TBL] [Abstract][Full Text] [Related]
58. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
60. Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.
Remschmidt C; Kaufmann AM; Hagemann I; Vartazarova E; Wichmann O; Deleré Y
Int J Gynecol Cancer; 2013 Mar; 23(3):519-26. PubMed ID: 23360813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
